果胶铋与阿莫西林联合用药治疗胃炎患者的临床分析.docVIP

精品论文 参考文献 果胶铋与阿莫西林联合用药治疗胃炎患者的临床分析 黄桂蛟 （四川省邛崃市医疗中心医院 611530） 【摘要】目的 探讨果胶铋与阿莫西林联合用药治疗胃炎患者的临床效果。方法 选取2013 年1 月-2014 年1 月在我院进行治疗的120 例胃炎患者为研究对象，根据用药方法不同，分为观察组（60 例）和对照组（60 例），观察组给予果胶铋联合阿莫西林治疗，对照组给予果胶铋和克拉霉素治疗。治疗结束后，比较并分析两组患者的治疗效果和幽门螺杆菌根除率。结果 观察组总有效率为96.6%，明显高于对照组的71.6%；观察组幽门螺杆菌根除率为96.6%，高于对照组幽门螺杆菌根除率的83.3%，两组比较，差异具有统计学意义（p ＜ 0.05）。结论 果胶铋与阿莫西林联合治疗胃炎患者具有显著效果，可提高治疗效果，增加患者食欲，改善患者生活质量，值得临床使用并推广。 【关键词】阿莫西林；果胶铋；胃炎 【中图分类号】 R2 【文献标号】 A 【文章编号】 2095-7165（2015）07-0026-02 【 abstract 】 objective to explore the pectic bismuth and amoxicillin the clinical effect of combination treatment of gastritispatients. Selection methods in January 2013 - January 2014 in our hospital for treatment of 120 cases of gastritis patients as theresearch object, according to different preparation method, divided into the observation group (60 cases) and control group (60 cases)and observation group was given pectic bismuth with amoxicillin therapy, the control group given pectic bismuth and clarithromycintherapy. After treatment, the comparison and analysis of the therapeutic effect of two groups of patients with helicobacter pylorieradication rates. Results observation group total effective rate was 96.6%, significantly higher than the control group 71.6%;Observation group of helicobacter pylori eradication rate was 96.6%, higher than control group in helicobacter pylori eradication rateof 83.3%, compared two groups, difference has statistical significance (p lt; 0.05). Conclusion bismuth pectin and amoxicillin combinedtreatment gastritis patients has significant effect, can improve the effect of treatment, patients with increased appetite and improvepatient quality of life, worthy of clinical use and promotion. 【 key words 】 amoxicillin. Pectic bismuth; gastritis 由于人们生活压力增大、节奏加快，大多数人饮食习惯较差，常常食用垃圾食品和快餐，有吸烟、喝酒等不良习惯，因此胃炎患者随之增加，并呈上升趋势。慢性萎缩性胃炎是胃炎最为常见的一种，约占接受胃镜检查患者的80%~90%，以胃黏膜上皮以及腺体萎缩，数目减少，胃黏膜变薄，黏膜肌层增厚为特征。临床症状表现为：上腹部隐痛、胀气、食欲不振，体征表现为：消瘦、贫血等，无特异性。胃炎治疗的关键是对